Results 26 - 50 from 107 for "pharma"
-
Fiterman Pharma 2019 Profit Doubles To RON13.5M, Turnover Grows 6% To RON139M
08.18.2020
Fiterman Pharma, a medium-size pharmaceuticals producer based in Iasi, on Tuesday said its profit doubled on the year to RON13.5 million and its turnover grew 6% on the year to RON139 million in 2019, more
-
A State-Of-The-Art Healthcare System Must Rely on Statistics about Patients and Medicines
09.17.2019
Implementation of prevention programs so as to lead to an efficient state-of-the-art healthcare system must come from statistical data about the health issues of the patients, which would provide an more
-
A&D Pharma Marketing&Sales Gets Antitrust Clearance to Acquire Teva Assets
06.05.2019
Romania's antitrust body has authorized the deal whereby A&D Pharma Marketing&Sales SRL takes over assets from Teva Pharmaceuticals SRL (Teva), mainly consisting of wholesale contracts concluded by more
-
Zentiva Gets Antitrust Clearance to Buy Solacium Brand from A&D Pharma
05.28.2019
Romania's antitrust body has cleared the deal whereby generics manufacturer Zentiva, owned by Advent International, took over the Romanian food supplement brand Solacium from A&D Pharma, owned by Dr. more
-
Fildas-Catena Beats A&D Pharma to Top Spot on Pharmaceutical Wholesale and Retail Market
05.17.2019
Fildas-Catena group held by entrepreneur Anca Vlad posted 7.7 billion lei (EUR1.6 billion) revenue in 2018 with its pharmaceutical wholesaler Fildas and pharmaceutical retailer Catena, up 40% over more
-
Patient Access To Care Can Be Improved By Redistribution Of Funds And Efficient Allocation
09.26.2018
Patient access to care can be improved by redistribution of the money in the system in line with actual needs, but we must also find solutions to make allocation efficient, said the speakers attending more
-
Romanian OTC Drug Market Grows 13% in 1Q, to RON880M
05.15.2018
Sales of over-the-counter (OTC) medicines topped RON880 million in Romania in the first quarter, up 13% on the year, the local producers association said Tuesday citing Cegedim data. more
-
New A&D Pharma Owner: Rebranding Process May Be Announced By Yearend
04.26.2018
Dr. Max pharmaceutical group, held by Czech Republic’s Penta Investments, has added 613 pharmacies to its network once the takeover of the A&D Pharma group has been completed. This will take the more
-
A&D Pharma Takeover By Glebi Holdings Gets Antitrust Approval With Conditions
04.23.2018
Romania’s Competition Council has approved the transaction whereby Glebi Holdings PLC is acquiring A&D Pharma Holdings NV, and the buyer has agreed to transfer 18 Arta pharmacies. more
-
Competition Council Looks Into A&D Pharma Takeover By Gebi Holdings
02.06.2018
-
A&D Pharma CEO Expects More Aggressive Expansion Under Penta Investment Umbrella
01.19.2018
The A&D Pharma group, which comprises the pharmaceutical wholesale market leader Mediplus and Sensiblu and Punkt retail pharmacy chains, will join Czech Republic’s Penta Investment group once one of more
-
Penta Investment Confirms A&D Pharma Acquisition
12.21.2017
Czech private equity firm Penta Investment has reached an agreement to acquire A&D Pharma, the largest group on Romania’s pharmaceutical market. The deal still requires antitrust clearance. more
-
Penta Investment – A&D Pharma Deal Close To Completion
12.05.2017
The deal whereby Czech private equity firm Penta Investment buys A&D Pharma, the largest group on Romania’s pharmaceutical market, is close to completion, as an agreement is due for signing by the more
-
Czech Investment Group In Talks To Buy A&D Pharma
10.12.2017
Czech Republic-based investment group Penta Investments has started talks for the acquisition of the largest pharmaceutical group in Romania, A&D Pharma, market sources say. more
-
Bondoc, Managing Partner Bondoc&Asociatii: Economic Pressure Leads To Consolidation In Pharma Sector
09.13.2017
-
Fiterman Pharma Sees EUR30M Revenue From Drug Production
06.28.2017
Pharmaceutical producer Fiterman Pharma, held by the Fiterman family in Iasi, which also owns the Arcadia medical group, ended last year with 135 million lei (EUR30 million) revenue and RON25 million more
-
BRD-Groupe Société Générale And UniCredit Bank Grant Over EUR177M Loan To A&D Pharma
06.15.2017
-
A&D Pharma Integrates 600 Independent Pharmacies Into Respiro Program
05.10.2017
-
Pharma Sector Dominates Ranking Of Firms Concluding The Biggest Public Procurement Contracts
12.02.2016
Farmexpert, one of the main pharmaceutical distributors, ranks first by the total value of contracts concluded online via the Electronic System for Public Procurement (SEAP), in a top five dominated more
-
ZF Health & Pharma '16: Romania’s Healthcare System Problems
09.14.2016
The lack of state-of-the-art equipment in public hospitals, the shortage of physicians in the medical facilities in various parts of the country due to migration abroad and to the private sector and more
-
Pharmaceutical Company Hexi Pharma Cannot Be Dissolved
05.16.2016
Judges ruled on Monday that Romanian pharmaceutical company Hexi Pharma cannot be liquidated or dissolved, cannot be subject to mergers, reduce share capital or alienate assets. more
-
Hexi Pharma Files For Insolvency
05.11.2016
Romanian pharmaceutical company Hexi Pharma, involved in the recent scandal with diluted disinfectants used in Romanian hospitals, filed for insolvency on May 10. more
-
Hexi Pharma, Sante International, G.B.Indco Control Nearly Two Thirds Of Local Disinfectants Market
05.09.2016
Three companies control the Romanian disinfectants market, with an overall market share of 63% and a turnover of nearly RON94 million at the end of 2014, according to a recent report by ICAP Romania. more
-
ZF Pharma Summit ’15: MedLife Eyes To Conclude At Least Three Transactions This Year
09.23.2015
MedLife, Romania's largest private medical services provider, plans to bring its Brasov-based unit among top-ten medical companies on the local market, said Mihai Marcu, president of MedLife Board of more
-
ZF Pharma Summit ’15: Pharmaceutical Industry Hurt By Drug Price Cuts
09.23.2015
The decline in drug prices, the constant increase in the clawback tax and the lack of transparency about how it is managed are affecting the pharmaceutical market in Romania. more